Repair or replace ischemic mitral regurgitation during coronary artery bypass grafting? A meta-analysis

Yushu Wang1, Xiuli Shi1, Meiqin Wen1

  • 1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.

Insights

Mitral valve replacement during coronary artery bypass grafting (CABG) for ischemic mitral regurgitation shows lower recurrence rates. Survival and reoperation rates were similar between repair and replacement groups in this meta-analysis.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Mitral Valve Disease

Background:

  • Optimal surgical management for chronic ischemic mitral regurgitation (IMR) during coronary artery bypass grafting (CABG) remains debated.
  • This meta-analysis compares clinical outcomes of mitral valve repair versus replacement in IMR patients undergoing CABG.

Purpose of the Study:

  • To meta-analyze and compare the clinical outcomes of mitral valve repair and replacement in patients with chronic ischemic mitral regurgitation undergoing CABG.

Main Methods:

  • A comprehensive literature search was conducted across major databases (PubMed, Embase, Ovid Medline, Cochrane Library).
  • Keywords included "ischemic mitral regurgitation," "mitral valve repair," "mitral valve replacement," and "coronary artery bypass grafting."
  • Primary outcomes were operative and late mortality; secondary outcomes included regurgitation recurrence and reoperation rates.

Main Results:

  • Eleven studies with 1750 patients were included; 60.4% underwent mitral valve repair.
  • No significant differences were observed in operative mortality (OR 0.65, p=0.05) or late mortality (HR 0.87, p=0.31).
  • Regurgitation recurrence was significantly lower following mitral valve replacement (OR 5.41, p<0.001), while reoperation rates showed no significant difference (OR 1.47, p=0.12).

Conclusions:

  • Mitral valve replacement in chronic IMR patients undergoing CABG is associated with reduced mitral regurgitation recurrence.
  • No significant differences in survival or reoperation rates were found between mitral valve repair and replacement.
Abstract

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
500
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
415
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
849
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
534
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
717
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
478